Published on 13 Mar 2024 on Zacks via Yahoo Finance
Roche (RHHBY) Launches AI-Based Predictive CGM Accu-Chek
Roche RHHBY has unveiled its latest innovation in diabetes care, paving its way into the continuous glucose monitoring (CGM) market, at the 17th International Conference on Advanced Technologies and Treatments for Diabetes in Florence, Italy. The new Accu-Chek SmartGuide solution for real-time CGM promises to revolutionize diabetes management with its predictive artificial intelligence (AI) capabilities, addressing critical unmet needs faced by individuals with diabetes.
Roche is currently working toward obtaining CE mark clearance for the Accu-Chek SmartGuide device. It will start introducing the solution in selected European countries soon after the clearance.
In the past six months, shares of RHHBY have declined 2.7% against the industry’s 11.5% growth. The S&P 500 has increased 12.7% during the same time frame.